Society for Surgery of the Alimentary Tract

SSAT Home SSAT Home Past & Future Meetings Past & Future Meetings

Program (Subject to Change)

65th Annual Meeting
SOCIETY FOR SURGERY OF THE ALIMENTARY TRACT
May 18-21, 2024
Walter E. Washington Convention Center | Washington D.C.
in partnership with Digestive Disease Week®


All rooms at Walter E. Washington Convention Center unless otherwise indicated.

Ticketed Session indicates a Ticketed Session requiring a separate registration and fee.
Residents Conference Indicates a Plenary presentation that is also being presented at the Resident & Fellows Research Conference.
Live Streamed Indicates a Live-streamed Session.

Tracks
Esophagus, Gastric, Bariatric, & Metabolic Education, Quality, Outcomes, & Policy
Hepatobiliary & Pancreas Colorectal
Peritoneal Surface, Abdominal Wall & Small Bowel General & Society Business

Program | Residents & Fellows | Posters

<< Sunday | Program | Tuesday >>

MONDAY, MAY 20, 2024
8:00 AM - 9:30 AM
Room 207B
PRESIDENTIAL PLENARY
 
Faculty: Vic Velanovich, Tampa, FL
View Audio Recording
 
Residents Conference 678. RISK FACTORS FOR REGROWTH AFTER NONOPERATIVE MANAGEMENT FOR RECTAL CANCER
Neal Bhutiani*, Kentaro Ochiai, Tsuyoshi Konishi, Oliver Peacock, Y. Nancy You, Brian K. Bednarski, Craig A. Messick, Atsushi Ikeda, Michael White, John M. Skibber, George J. Chang, Abhineet Uppal
Surgical Oncology, The University of Texas MD Anderson Cancer Center Division of Surgery, Houston, TX
 
Residents Conference 679. LONG-TERM RESULTS OF LAPAROSCOPIC HELLER-DOR FOR ESOPHAGO-GASTRIC JUNCTION OUTFLOW OBSTRUCTION: A PROSPECTIVE CONTROLLED TRIAL
Francesca Forattini*, Luca Provenzano, Mario Costantini, Giulia Nezi, Giovanni Capovilla, Andrea Costantini, Lucia Moletta, Loredana Nicoletti, Michele Valmasoni, Renato Salvador
Department of Surgical, Oncological and Gastroenterological Sciences,, Universita degli Studi di Padova, Padova, Veneto, Italy
 
Residents Conference 680. CARCINOEMBRYONIC ANTIGEN INCREASE AFTER PREOPERATIVE CHEMOTHERAPY DISCONTINUATION PREDICTS RECURRENCE AND WORSE SURVIVAL AFTER RESECTION OF COLORECTAL LIVER METASTASES
Antony Haddad*, Mateo Lendoire, Abhineet Uppal, Harufumi Maki, Reed I. Ayabe, Timothy E. Newhook, Yun Shin Chun, Ching-Wei D. Tzeng, Jean-Nicolas Vauthey, Hop S. Tran Cao
The University of Texas MD Anderson Cancer Center Division of Surgery, Houston, TX
 
Residents Conference 681. EXERCISE STIMULATES ANTITUMORAL IMMUNITY IN PANCREATIC DUCTAL ADENOCARCINOMA
Mansour E. Riachi*1,2, Carolina G. Alcantara Hirsch1,2, Anthony Sorrentino1,2, Erica Ma1, Beny Shapiro1, Christopher L. Wolfgang1,2, Dafna Bar-Sagi1,2
1NYU Langone Health, New York, NY; 2New York University Grossman School of Medicine, New York, NY
 
682. COMPARISON OF ADAPTED ENHANCED RECOVERY AFTER SURGERY (ERAS) PATHWAY VERSUS STANDARD CARE IN PATIENTS UNDERGOING EMERGENCY ABDOMINAL SURGERY - A RANDOMIZED CONTROLLED TRIAL
Vikram Kate*1, Likhita S. Singh1, Gurushankari Balakrishnan2, Sathasivam Sureshkumar1, Amaranathan Anandhi1, Thulasingam Mahalakshmy3, Pankaj Kundra4
1Department of Surgery, Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry, India; 2Department of Surgical Oncology, Cancer institute (WIA), Adyar, Pondicherry, India; 3Department of Preventive and Social Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry, India; 4Department of Anaesthesia and Critical Care, Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry, India
 
Residents Conference 683. ENDOSCOPIC THERAPIES FOR POST-BARIATRIC GASTRIC SLEEVE LEAKS: A COMPREHENSIVE 10-YEAR ANALYSIS OF EFFICACY, SAFETY, AND OUTCOMES
Kimberly F. Schuster*1,2, Cem Simsek3, Christopher C. Thompson1
1Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, Boston, MA; 2Tufts University School of Medicine, Boston, MA; 3Hacettepe Universitesi Tip Fakultesi, Ankara, Ankara, Turkey
10:00 AM - 10:45 AM
Room 207B
PRESIDENTIAL ADDRESS
 
Sp773
INTRODUCTION OF SSAT PRESIDENT
Ranjan Sudan
Duke University Medical Center, Durham, NC

Sp774
PRESIDENTIAL ADDRESS: "Meaning"
Vic Velanovich
USF, Tampa, FL
View Presidential Address
10:45 AM - 11:30 AM
Room 207B
DORIS AND JOHN L. CAMERON GUEST ORATION
 
Faculty: Vic Velanovich, Tampa, FL

Sp849
ORATION TITLE: "Executive Brain Vitality"
Michael Hoffmann
University of Central Florida, Orange County, FL
12:30 PM - 1:30 PM
Hall A, Poster Hall
POSTER SESSION II: HEPATOBILIARY TRACT & STOMACH/BARIATRIC METABOLIC DISEASES (NON-CME)
 
Hepatobiliary Tract Moderators: Allison Martin, Houston, TX
Daniel Nelson, Houston, TX
Stomach/Bariatric/Metabolic Moderators: Alex Escalona, Santiago, Chile
Kaitlyn Kelly, Madison, WI

Authors available at their posters to answer questions 12:30 pm - 1:30 pm; posters on display 9:30 AM - 4 PM.

2:00 PM - 3:30 PM
Room 206
SSAT DIVERSITY SYMPOSIUM: DIVERSITY & INCLUSION LIAISON COMMITTEE: PRACTICAL STEPS TO BECOMING A DEI-FOCUSED GI SURGERY PROGRAM
 
Moderators: Haejin In, New Brunswick, NJ
Alia Qureshi, Portland, OR

Sp923
WHY ARE DEI INITIATIVES IMPORTANT IN GI SURGERY?
Steven C. Stain
Surgery, Albany Medical College, Albany, NY

Sp924
HOW TO GET STARTED: TOP-DOWN APPROACH
Chelsea Dorsey
University of Chicago Division of the Biological Sciences, Chicago, IL

Sp925
HOW TO GET STARTED: DOWN-UP APPROACH
Prakash K. Pandalai
University of Kentucky, Lexington, KY

Sp926
RESEARCH EFFORTS TO DIVERSIFY THE WORKFORCE
Heather Yeo
Weill Cornell, New York, NY

Q&A PANEL DISCUSSION
2:00 PM - 3:30 PM
Room 207A
ORAL SESSION: PANCREATIC DISEASES II
 
Faculty: Keiichi Akahoshi, Tokyo, Japan
Louisa Bolm, Boston, MA
Sajid Khan, New Haven, CT
 
816. FROM TRENDS TO TRAJECTORIES: A 5-YEAR NATIONWIDE ASSESSMENT OF OPEN AND MINIMALLY INVASIVE PANCREATICODUODENECTOMY
Bibek Aryal, Yue Yin, Edward A. Joseph*, Sricharan Chalikonda, David Bartlett, Casey Allen
Surgical Oncology, Allegheny Health Network, Pittsburgh, PA
 
817. ASSOCIATION OF PREOPERATIVE CHOLANGITIS WITH OUTCOMES AND EXPENDITURES AMONG PATIENTS UNDERGOING PANCREATICODUODENECTOMY
Zayed Rashid*, Selamawit Woldesenbet, Mujtaba Khalil, Muhammad Muntazir Mehdi Khan, Yutaka Endo, Diamantis Tsilimigras, Erryk Katayama, Muhammad Muntazir M. Khan, Abdullah Altaf, Mary Dillhoff, Timothy M. Pawlik
Surgery, The Ohio State Wexner Medical Center, Columbus, OH
 
818. STRATIFICATION OF MANAGEMENT OF POSTOPERATIVE FLUID COLLECTIONS BY POST-RECONSTRUCTION ANATOMIC ZONES IN PANCREATICODUODENECTOMY PATIENTS
Jean Namgoong*1, Grace C. Bloomfield1, Piyush Gupta2, Aradhya Nigam2, Vasalya Panchumarthi1, Thomas Fishbein2, Pejman Radkani2, Emily R. Winslow3
1Georgetown University School of Medicine, Washington, ; 2MedStar Georgetown University Hospital, Washington, ; 3University of Wisconsin-Madison, Madison, WI
 
819. CHYLE LEAK FOLLOWING PANCREATIC RESECTION: AN UNDERAPPRECIATED CAUSE OF DELAYED POSTOPERATIVE RECOVERY
Grace C. Bloomfield*1, Jean Namgoong1, Piyush Gupta2, Aradhya Nigam2, Thomas Fishbein2, Pejman Radkani2, Emily R. Winslow2
1Medical Student, Georgetown University School of Medicine, Washington, ; 2Georgetown University Medical Center, Washington,
 
820. FASTING RELATED AUTOPHAGY DECREASES THE SEVERITY OF ACUTE PANCREATITIS IN A RODENT MODEL OF SEVERE DISEASE
Marcel C C. Machado*, Marcia K. Koike, Denise F. Barbeiro, Francisco G. Soriano
University of São Paulo - School of Medicine, São Paulo, Brazil
 
821. QUALITY OF LIFE AND SOCIAL HEALTH IN PATIENTS AFTER PANCREATIC SURGERY
Nicholas Galouzis*, Maria K. Fotinos, Evelyn V. Alexander, Mohammad Khreiss, Carrie Luu, Lusine Mesropyan, Taylor S. Riall
Department of Surgery, Banner - University Medical Center Tucson, Tucson, AZ
 
822. READMISSION AFTER DISTAL PANCREATECTOMY FOR CHRONIC PANCREATITIS: COMMON AND CONSEQUENTIAL
Katelyn Flick*, Kyle A. Lewellen, James Butler, Eugene P. Ceppa, Ryan J. Ellis, Michael G. House, Trang Nguyen, Alexandra M. Roch, C. Max Schmidt, Nicholas J. Zyromski, Thomas K. Maatman
Indiana University School of Medicine, Indianapolis, IN
 
823. TOTAL NEOADJUVANT THERAPY IN DISTAL PANCREATIC ADENOCARCINOMA: DOES LOCATION IMPACT THERAPY RESPONSE?
Andrew B. Crocker*1, Maryclare E. Taylor1, Emily Papai1, Max Perilstein2, Malek Maddah2, Karen Ruth1, Anthony Villano1, Sanjay S. Reddy1
1Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA; 2Lewis Katz School of Medicine at Temple University, Philadelphia, PA
 
824. SBRT AFTER NEOADJUVANT CHEMOTHERAPY (NAC) FOR LOCALLY ADVANCED PANCREATIC CANCER (LAPC): PRELIMINARY INSTITUTIONAL RESULTS
Aikaterini Dedeilia*1, Georgios Kritselis3, Nikiforos Ballian2, Nikolaos Giakoumakis2, Grigorios Tsiotos2
1Surgery, Massachusetts General Hospital, Boston, MA; 2Mitera-Hygeia Hospital, Department of Surgery, Marousi, Greece; 3Mitera-Hygeia Hospital, Department of Radiation Oncology, Marousi, Greece
 
825. ASSESSING THE DIAGNOSTIC CONCORDANCE BETWEEN SURGEONS AND RADIOLOGISTS IN PANCREATIC CYST IMAGING
Gerik Cervantes*1, juan malo2, Houssam Osman2, D Rohan Jeyarajah2
1Texas Christian University Anne Burnett Marion School of Medicine, Fort Worth, TX; 2Methodist Richardson Medical Center, Richardson, TX
 
826. COMPARATIVE ANALYSIS OF LAPAROSCOPIC AND ROBOTIC DISTAL PANCREATECTOMY: BALANCING PERIOPERATIVE OUTCOMES AND COSTS
Edward A. Joseph*1, Bibek Aryal1, Tyson Barrett2, Patrick Wagner1, David Bartlett1, Sricharan Chalikonda1, Casey Allen1
1Surgical Oncology, Allegheny Health Network, Pittsburgh, PA; 2Highmark Health, Pittsburgh, PA
 
827. DEVELOPMENT OF NONALCOHOLIC FATTY LIVER DISEASE AFTER PANCREATICODUODENECTOMY: A SYSTEMATIC REVIEW AND META-ANALYSIS
Ronnakorn Kongsakon*, Wasit Wongtrakul, Khemajira Karaketklang, Nonthalee Pausawasdi, Phunchai Charatcharoenwitthaya
Mahidol University Faculty of Medicine Siriraj Hospital, Bangkok, Thailand
 
828. NEOADJUVANT CHEMOTHERAPY VERSUS UPFRONT SURGERY IN RESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA: A NATIONAL CANCER DATABASE INTENTION-TO-TREAT ANALYSIS
Joanna T. Buchheit*, Cynthia E. Burke, Charles C. Vining, Rushin D. Brahmbhatt, June S. Peng
Penn State College of Medicine, Hershey, PA
 
829. UNDERSTANDING FRAGMENTED PANCREATIC CANCER CARE IN PATIENTS RECIEVING NEOADJUVANT THERAPY: ARE SOCIODEMOGRAPHIC DISPARITIES PREDICTIVE OF PATIENTS RECEIVING FRAGMENTED CARE?
Maryclare E. Taylor*1,2, Andrew B. Crocker2, Emily Papai1,2, Max Perilstein1, Malek Maddah1, Karen Ruth2, Anthony Villano2, Sanjay S. Reddy2
1Surgery, Temple University Hospital, Philadelphia, PA; 2Fox Chase Cancer Center, Philadelphia, PA
 
830. COMPARING ONCOLOGIC AND SURGICAL OUTCOMES OF ROBOTIC AND LAPAROSCOPIC PANCREATICODUODENECTOMY: A PROPENSITY-MATCHED ANALYSIS
Chase J. Wehrle*1, Jenny H. Chang1, Abby Gross1, Kimberly P. Woo1, Robert Naples1, Kathryn A. Stackhouse1, Fadi Dahdaleh2, Toms Augustin1, Daniel Joyce1, Robert Simon1, R Matthew Walsh1, Samer A. Naffouje1
1Cleveland Clinic, Cleveland, OH; 2Edward Elmhurst Health Marquardt Memorial Library, Elmhurst, IL
 
831. IMPACT OF INSTITUTIONAL RADIOTHERAPY VOLUME ON POSTOPERATIVE AND ONCOLOGIC OUTCOMES AFTER NEOADJUVANT RADIATION FOR PANCREATIC CANCER
Raja R. Narayan*1,2, Anne Pannekoek1, Mengyuan Ruan1, Ritchell van Dams1,2, George Molina1,2
1Surgery, Brigham and Women's Hospital, Boston, MA; 2Dana-Farber/Harvard Cancer Center, Boston, MA
2:00 PM - 3:30 PM
Room 207B
ORAL SESSION: STOMACH/BARIATRIC/METABOLIC DISEASES II
 
Moderators: Antonio Picon, Irving, NY
Yuki Harata, Tokyo, Japan
Victoria Gershuni, St. Louis, MO
 
832. CAUSES FOR REOPERATION AFTER GASTRIC NEUROSTIMULATOR IMPLANTATION
Katherine Englander*, Samer Ganam, Tejasvi Paturu, Joseph Sujka, Vic Velanovich
USF, Tampa, FL
 
833. RESTORE OR RENOVATE? REVISIONAL ENDOSCOPIC SLEEVE GASTROPLASTY (R-ESG) VERSUS (RYGB) ROUX-EN-Y GASTRIC BYPASS FOR WEIGHT REGAIN FOLLOWING SLEEVE GASTRECTOMY (SG)
Abdellah Hedjoudje*1, Anna C. Hoff2, Gabriel C. Nunes2, Sergio Barrichello2, Induja R. Nimma1, Vivek Kumbhari1, Dilhana S. Badurdeen1
1Mayo Clinic in Florida, Jacksonville, FL; 2Angioskope, Sao Paulo, Brazil
 
834. PRE-OPERATIVE SERUM CREATININE PREDICTS MORBIDITY AND MORTALITY IN METABOLIC AND BARIATRIC SURGERY - AN MBSAQIP PROPENSITY SCORE MATCHED ANALYSIS
Steven M. Elzein*1, Daniel Tomey1, Sara Butt1, Maria Corzo1, Halil Bulut5, Sachin Shetty3, Suman Shetty8, Victor G. Peña1, Roberto Secchi del Rio9, Nnenna A. Osagwu7, Victor Bolivar6, Adel Abou-Mrad4, Rodolfo J. Oviedo2
1Surgery, Houston Methodist Hospital, Houston, TX; 2Nacogdoches Center for Metabolic and Weight Loss Surgery, Nacogdoches, TX; 3Baylor College of Medicine, Houston, TX; 4Centre Hospitalier Regional d'Orleans, Orleans, Centre-Val de Loire, France; 5Royal Brompton and Harefield Hospitals, London, United Kingdom; 6Universidad de Oriente, Cumana, Sucre, Venezuela, Bolivarian Republic of; 7All Saints University School of Medicine, Roseau, Saint George, Dominica; 8The University of Texas at Austin, Austin, TX; 9Universidad Anahuac Queretaro, Santiago de Queretaro, Querétaro, Mexico
 
835. TRENDS IN THE ADOPTION OF ROBOTIC GASTRECTOMY FOR GASTRIC CANCER
Shruti Koti*, Neda Amini, Martin S. Karpeh
Department of Surgery, Northwell Health, New Hyde Park, NY
 
836. THE USE OF SLEEVE GASTRECTOMY FOR ELDERLY AND FRAIL OBESE PATIENTS IS SAFE, AND IT RESOLVES THEIR COMORBIDITIES IN MOST CASES
Eliahu Y. Bekhor*1,2, Nayyera Tibi1,2, Noam Peleg1,2, Hila Shmilovich1,2, lisa cooper1,2, boris kirstein1,2, Issa Nidal1,2
1Rabin Medical Center, Petah Tikva, Central, Israel; 2Tel Aviv University, Tel Aviv, Tel Aviv, Israel
 
837. RISK FACTORS FOR PULMONARY EMBOLISM IN POSTOPERATIVE PATIENTS: DEVELOPMENT OF A RISK ASSESSMENT TOOL FOR CLINICAL DECISION MAKING AND USE OF COMPUTED TOMOGRAPHY PULMONARY ANGIOGRAPHY
Ilaria Caturegli*1, Biqi Zhang1, Baokun Gu2, Bidisha Das1, Mark M. Hammer1, Jiping Wang1
1Brigham and Women's Hospital, Boston, MA; 2Stanford University School of Medicine, Stanford, CA
 
838. SURVIVAL DIFFERENCES FOR PATIENTS WITH GASTRIC CANCER IN THE US AND BRAZIL: A CROSS-SECTIONAL ANALYSIS OF TWO NATIONAL DATASETS
Daniel J. Szor*2, Kaleem S. Ahmed1, Cibele Barbosa Carroll1, Taylor Jaraczewski3, Francisco Tustumi2, Ulysses Ribeiro2, Noelle K. LoConte1, Nataliya Uboha1, Kaitlyn J. Kelly1, Syed Nabeel Zafar1
1Surgery, University of Wisconsin-Madison, Madison, WI; 2Universidade de Sao Paulo, Sao Paulo, Brazil; 3Medical College of Wisconsin, Milwaukee, WI
 
839. TRENDS IN NEOADJUVANT CHEMOTHERAPY UTILIZATION AND TREATMENT SEQUENCING FOR GASTRIC CANCER: ARE WE MAKING PROGRESS?
Alexandra E. Hernandez*, Yujie Wang, Jodie A. Barkin, Alan S. Livingstone, Mehmet Akcin, Cheng-Bang Chen, Laurence R. Sands, Jose M. Martinez, Danny Sleeman, Onur Kutlu
Surgery, University of Miami, Coral Gables, FL
 
840. A NOVEL TECHNIQUE OF ENDOSCOPIC MAGNETIC COMPRESSION IN GASTROSTOMY
Fei Xue*
General Surgery, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, China
 
841. DIFFERENCES IN PATIENT OUTCOMES CANNOT EXPLAIN HIGHER MORTALITY FROM GASTRIC ADENOCARCINOMA IN RACIAL/ETHNIC POPULATIONS: AN ANALYSIS OF THE NCDB
Alexandra Adams*1, Brijesh Rana1, Brett L. Ecker1, Mariam F. Eskander1, Timothy Kennedy1, Miral S. Grandhi1, Russell Langan1, Henry A. Pitt1, Haejin In1,2
1Surgical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; 2Rutgers School of Public Health, Piscataway, NJ
 
842. MECHANISMS OF GASTROESOPHAGEAL REFLUX POST-ROUX-EN-Y GASTRIC BYPASS: UNIVERSAL ALTERATION OF THE ANTI-REFLUX BARRIER IS THE CULPRIT
Karim Al Annan*, Razan Nabeel Mousa Aburumman, Rudy Mrad, Khushboo Gala, Barham K. Abu Dayyeh
Gastroenterology and Hepatology, Mayo Clinic Minnesota, Rochester, MN
 
843. MINIMALLY INVASIVE SURGERY FOR GASTRIC ADENOCARCINOMA IS ASSOCIATED WITH BETTER SHORT-TERM OUTCOMES WITHOUT COMPROMISE IN LONG TERM AND ONCOLOGICAL OUTCOMES
Alexandra E. Hernandez*1, Yujie Wang1, Jodie A. Barkin2, Alan S. Livingstone1, Mehmet Akcin1, Cheng-Bang Chen1, Laurence R. Sands1, Jose M. Martinez1, Danny Sleeman1, Onur Kutlu1
1Surgery, University of Miami, Coral Gables, FL; 2University of Miami Miller School of Medicine, Miami, FL
 
844. BOTULINUM TOXIN PYLOROPLASTY TO REDUCE POST-OPERATIVE NAUSEA AND VOMITING AFTER SLEEVE GASTRECTOMY: A PILOT RANDOMIZED TRIAL
Grishma Pradhan*, Tyler Robinson, Ashar Ata, Tejinder P. Singh, Jessica Zaman
General Surgery, Albany Medical Center, Albany, NY
 
845. EFFICACY OF GPOEM (GASTRIC PERORAL ENDOSCOPIC MYOTOMY) FOR REFRACTORY GASTROPARESIS: A META-ANALYSIS
Vishal Chandel*1, Veronica West2, Neel Chandel3
1Internal Medicine, Suburban Community Hospital, East Norriton, PA; 2Philadelphia College of Osteopathic Medicine, Philadelphia, PA; 3St Mary Medical Center, Langhorne, PA
 
846. THE SAFETY AND TECHNICAL FEASIBILITY OF ENDOSCOPIC SUBMUCOSAL DISSECTION FOR EARLY GASTRIC CANCER AMONG PATIENTS ?75 YEARS OF AGE - A SYSTEMATIC REVIEW AND META-ANALYSIS
Maryam Rafaqat Hussain*2, Faisal S. Ali1, Brian Downer2, Vaibhav Wadhwa1, Tomas DaVee1, Nirav Thosani2
1The University of Texas Health Science Center at Houston, Houston, TX; 2The University of Texas Medical Branch at Galveston, Galveston, TX
 
847. PATHOLOGICAL COMPLETE RESPONSE (PCR) TO DURVALUMAB PLUS 5-FLUOROURACIL, LEUCOVORIN, OXALIPLATIN AND DOCETAXEL (FLOT) IN RESECTABLE GASTRIC AND GASTROESOPHAGEAL JUNCTION CANCER (GC/GEJC): REGIONAL SUBGROUP ANALYSIS FROM THE PHASE 3 MATTERHORN STUDY
Molena, Daniela1*, Janjigian, Yelena2, Al-Batran, Salah-Eddin3, Wainberg, Zev A.4, Van Cutsem, Eric5; Muro, Kei6; Hyung, Woo J.7; Wyrwicz, Lucjan8; Oh, Do-Youn9; Omori, Takeshi10; Moehler, Markus11; Garrido, Marcelo12; Oliveira, Sulene C.13; Liberman, Moishe14; Castro Oliden, Victor15; Bilici, Mehmet16; Kurland, John F.17; Xynos, Ioannis18; Mann, Helen18; Tabernero, Josep19
1Division of Thoracic Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, United States; 2Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, United States; 3Institute of Clinical Cancer Research, Krankenhaus Nordwest, University Cancer Center, Frankfurt, Germany; 4Department of Gastrointestinal Medical Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States; 5Department of Gastroenterology/Digestive Oncology, University Hospitals Leuven and KU Leuven, Leuven, Belgium; 6Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan; 7Department of Surgery, Yonsei University College of Medicine, Seoul, Korea (the Republic of); 8Department of Oncology and Radiotherapy, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland; 9Division of Medical Oncology, Department of Internal Medicine, Seoul National University Hospital; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea (the Republic of); 10Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan; 11Research Center for Immunotherapy (FZI), Johannes Gutenberg-University Clinic, Mainz, Germany; 12SAGA Clinical Trial Centre and Universidad Mayor, Santiago, Chile; 13Clinical Oncology, The Clinical Research Center, Northern Riograndense League Against Cancer, Natal, Rio Grande do Norte, Brazil; 14Division of Thoracic Surgery, Department of Surgery, Centre Hospitalier de l'Université de Montréal, Centre de Recherche du CHUM, Montréal, QC, Canada; 15National Institute of Neoplastic Diseases (INEN), Lima, Peru; 16Department of Medical Oncology, Atatürk University Faculty of Medicine, Erzurum, Turkey; 17AstraZeneca, Gaithersburg, MD, United States; 18AstraZeneca, Cambridge, None Selected, United Kingdom; 19Medical Oncology Department, Vall d’Hebron Hospital Campus & Institute of Oncology (VHIO), IOB-Quiron, UVic-UCC, Barcelona, Spain
2:00 PM - 3:30 PM
Room 154AB
Live Streamed DDW COMBINED CLINICAL SYMPOSIUM: AASLD-SSAT: MULTI-DISCIPLINARY APPROACH TO THE MANAGEMENT OF MASLD AND OBESITY
 
Faculty: Eduardo Vilar-Gomez, Indianapolis, IN
Cynthia Moylan, Durham, NC

Sp870
FROM NAFLD TO MASLD: MORE THAN JUST A NEW ABBREVIATION
Tania Mitsinikos
University of Southern California, Los Angeles, CA

Sp871
CHALLENGES AND OPPORTUNITIES FOR MASLD DETECTION AND RISK STRATIFICATION
Mohammad Shadab Siddiqui
Virginia Commonwealth University Health System, Richmond, VA

Sp872
PHARMACOLOGIC APPROACHES TO MASLD TREATMENT
Kathleen E. Corey
Massachusetts General Hospital, Boston, MA

Sp873
NON-PHARMACOLOGIC THERAPIES FOR MASLD: LIFESTYLE, ENDOBARIATRICS, AND BARIATRIC SURGERY
Violeta Popov
Medicine, NYU Langone Health, New York, NY

Sp874
ADDRESSING ACCESS AND HEALTH DISPARITIES FOR MASLD ACROSS THE CLINICAL AND RESEARCH SPECTRUM
Nicole E. Rich
Division of Digestive and Liver Diseases, UT Southwestern Medical Center, Dallas, TX
4:00 PM - 5:30 PM
Room 206
PLENARY SESSION: BEST OF STOMACH/BARIATRIC/METABOLIC DISEASES
 
Faculty: Sachiyo Nomura, Tokyo, Japan
Brian Davis, El Paso, TX
Karen Gibbs, New Haven, CT
 
Residents Conference 948. DIABETES MICROVASCULAR AND MACROVASCULAR COMPLICATIONS PREDICT DIABETES REMISSION AFTER BARIATRIC SURGERY
Wissam Ghusn*2,1, Marita Salame2, Karl Hage2, Khushboo Gala2, Andrew C. Storm2, Barham K. Abu Dayyeh2, Andres Acosta2, Omar M. Ghanem2
1Internal Medicine, Boston University, Boston, MA; 2Mayo Foundation for Medical Education and Research, Rochester, MN
 
Residents Conference 949. ORAL MICROBIOME SIGNATURES AS POTENTIAL BIOMARKERS FOR GASTRIC CANCER RISK ASSESSMENT
Shruthi R. Perati*1, Mykhaylo Usyk2, Alexandra Adams3, Brijesh Rana3, Julie Yang4, Srawani Sarkar2, Fei Wang2, Laurence P. Diggs5, Christopher C. Sollecito2, Robert D. Burk2, Haejin In3
1Department of Surgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ; 2Department of Pediatric (Genetic Medicine), Albert Einstein College of Medicine, Bronx, NY; 3Division of Surgical Oncology, Rutgers Cancer Institute, New Brunswick, NJ; 4Division of Gastroenterology, Mount Sinai Hospital, New York, NY; 5Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
 
Residents Conference 950. EFFICACY OF GASTRIC-STIMULATOR AS AN ADJUNCT TO PYLOROPLASTY FOR GASTROPARESIS: CHARACTERIZING PATIENTS SUITABLE FOR SINGLE-PROCEDURE VS DUAL PROCEDURE APPROACH
Sven Eriksson*1, Margaret Gardner1, Inanc Sarici1, Ali H. Zaidi1, Ping Zheng1, Blair Jobe1,2, Shahin Ayazi1,2
1Esophageal Institute, Department of Surgery, Allegheny Health Network, Pittsburgh, PA; 2Department of Surgery, Drexel University College of Medicine, Philadelphia, PA
 
951. EFFECTS OF BARIATRIC SURGERY ON MORTALITY AND INPATIENT COMPLICATIONS IN PATIENTS HOSPITALIZED WITH DECOMPENSATED CIRRHOSIS: A NATIONWIDE ANALYSIS
Stephen A. Firkins*, Yazan Abu Omar, Roma Patel, Heesoo Yoo, Alvin Kwon, Bailey Flora, Jeffrey Shu, Alison Zhao, Meghana Iyer, Roberto Simons-Linares
Gastroenterology, Cleveland Clinic, Cleveland, OH
 
952. GASTRIC POLYPOSIS AND RISK OF GASTRIC CANCER IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS (FAP) SYNDROME
Rachel V. Christenson*1, Shubham Sood2, Robert A. Vierkant3, Daniel Schupack2, Lisa Boardman2, Travis E. Grotz4
1Mayo Clinic Department of Surgery, Rochester, MN; 2Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN; 3Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN; 4Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Mayo Clinic, Rochester, MN
 
953. MAGETIC SPHINCTER AUGMENTION VERSUS SUBTOTAL GASTRECTOMY WITH ROUX-EN-Y RECONSTRUCTION FOR THE TREATMENT OF POST-SLEEVE GASTRECTOMY GASTROESOPHAGEAL REFLUX DISEASE
Rachel S. Jefferies*1,2, Marc Ward1,3, Rehma Shabbir1, Daylon Farias1,2, Gerald Ogola1, Steven G. Leeds1,3
1Baylor Scott & White Health, Dallas, TX; 2University of North Texas Health Science Center, Fort Worth, TX; 3Baylor University Medical Center at Dallas, Dallas, TX
4:00 PM - 5:30 PM
Room 207A
PLENARY SESSION: BEST OF COLORECTAL DISEASES
 
Faculty: Jacquelyn Turner, New Orleans, LA
V. Prasad Poola, Springfield, IL
Tsuyoshi Konishi, Houston, TX
 
942. TREATMENT OF RECTAL CANCER BY TOTAL NEOADJUVANT THERAPY AND TRANSANAL LIMITED LOCAL EXCISION FOR COMPLETE RESPONDERS: PHASE II TRIAL RESULTS
Jasneet S. Bhullar*2, Amer Alame1, Ernesto Drelichman2, Mohammed Barawi1, Amer Zeni2, Zyad Kafri1, Elon Knoll3, Yakan Adli2, Wajahat Khan3, Amr Aref1
1Ascension St John Hospital, Detroit, MI; 2Ascension Providence Hospital Southfield Campus, Southfield, MI; 3Ascension Macomb-Oakland Hospital Warren Campus, Warren, MI
 
943. THE MICROBIOTA AT THE TIME OF SURGERY IS SIGNIFICANTLY ENRICHED WITH PRO-TUMORIGENIC BACTERIA IN PATIENTS WHO DEVELOP A POSTOPERATIVE RECURRENCE
Meejeon Roh, Mohsen Rouhani Ravari*, Claire Wild, Mason Vierra, Ryan B. Morgan, Lindsay Alpert, Nicholas R. Suss, Olga Zaborina, Benjamin D. Shogan
University of Chicago Division of the Biological Sciences, Chicago, IL
 
Residents Conference 944. CAN TUMOR RESPONSE TO INDUCTION CHEMOTHERAPY PREDICT TME-FREE SURVIVAL AFTER TOTAL NEOADJUVANT THERAPY FOR LOCALLY ADVANCED RECTAL CANCER?
Hussein K. Gharib*, Susan Szpunar, Zyad Kafri, Elon Knoll, Wajahat Khan, Adli Yakan, Mohammed Barawi, Ernesto Drelichman, Amer Alame, Amer Zeni, Amr Aref
Hematology/Oncology, Ascension St John Hospital, Detroit, MI
 
Residents Conference 945. SHOULD THE ADENOMA DETECTION RATE QUALITY METRIC VARY BY AGE: AN EXPLORATORY ANALYSIS
Charmee Mehta*, Dmitry Tumin, Michael Honaker
Surgery, East Carolina University, Greenville, NC
 
946. DOES SURGERY FOR IBD DELIVER ON IT'S PROMISES? IMPACT OF SURGERY ON SHORT-TERM PATIENT REPORTED OUTCOMES FROM THE CROHN'S & COLITIS FOUNDATION'S SURGICAL INNOVATIONS, RESEARCH, & QUALITY COLLABORATIVE
Stefan D. Holubar*1, Samuel Eisenstein2, Karen Zaghiyan5, Kinga S. Olortegui4, Muneera Kapadia7, Sarah Stringfield6, Alessandro Fichera6, Phillip Fleshner5, Neil Hyman4, Roger D. Hurst4, Jeremy M. Lipman1, Nicole Lopez2, Lisa A. Parry2, Benjamin D. Shogan4, Jonathan Stem7, Sonia Ramamoorthy2, Katerina O. Wells6, Caroline Perry3, Megan Villarreal3, Alandra Weaver3, Caren Heller3
1Colon and Rectal Surgery, Cleveland Clinic, Cleveland, OH; 2University of California San Diego, La Jolla, CA; 3Crohn's & Colitis Foundation, New York, NY; 4University of Chicago Pritzker School of Medicine, Chicago, IL; 5Cedars-Sinai Medical Center, Los Angeles, CA; 6Baylor Scott & White Health, Dallas, TX; 7The University of North Carolina at Chapel Hill, Chapel Hill, NC
 
Residents Conference 947. IMPACT OF PREOPERATIVE USE OF BIOLOGICS ON 30-DAY SURGICAL MORBIDITY AND MORTALITY IN PATIENTS WITH CROHN'S DISEASE UNDERGOING ILEOCOLECTOMY: NSQIP DATABASE ANALYSIS
Fady Daniel*, Mohamad Ali Ibrahim, Zakaria El Kouzi, Mohamad Khalife, Walaa G. El Sheikh, Hani Tamim
Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
4:00 PM - 5:00 PM
Room 207B
LEGENDS OF SURGERY
 
Sp933
Carlos A. Pellegrini
Chair, University of Washington, Seattle, Washington

Nathaniel J. Soper
Surgery, University of Arizona College of Medicine-Phoenix, Phoenix, AZ
Interviewer: Vic Velanovich, USF, Tampa, FL
Panelists: Allison N. Martin, Surgical Oncology, The University of Texas MD Anderson Cancer Center Division of Surgery, Houston, TX
Jenny H. Chang, Surgery, Cleveland Clinic, Cleveland, OH
5:00 PM - 5:30 PM
Room 207B
ANNUAL BUSINESS MEETING (Members Only)
 
Moderator: Vic Velanovich, Tampa, FL
4:00 PM - 5:30 PM
Room 152AB
DDW SHARK TANK (NON-CME)
 
Sponsored by: AGA, AASLD, ASGE, SSAT
Moderators: Michael Kochman, Philadelphia, PA
Scott Fraser, Malvern, PA

Sp936
WELCOME AND SHARK INTRODUCTIONS
Michael Kochman, Philadelphia, PA
Scott Fraser, Malvern, PA

Sp937
AASLD SHARK
Scott Friedman

SP938
AGA SHARK
Naresh Gunaratnam

Sp939
ASGE SHARK
Nalini Guda

Sp940
SSAT SHARK
Brian Dunkin

Sp941
AASLD INNOVATOR
Patricia Bloom

Sp942
AGA INNOVATOR
Renumathy Dhanasekaran
Vetri Venthan Elango

Sp943
ASGE INNOVATOR
Jianhua Tau

SP944
SSAT INNOVATOR
Bara El Kurdi
4:00 PM - 5:30 PM
Room 154AB
Live Streamed DDW COMBINED CLINICAL SYMPOSIUM: GASTROPARESIS
 
Faculty: Sergio Bardaro, Cleveland, OH
Ronnie Fass, Beachwood, OH
Alia Qureshi, Portland, OR

Sp948
TYPES OF GASTROPARESIS PATIENTS
Michael Sarr
Surgery, Mayo Clinic, Cave Creek, AZ

Sp949
EVALUATION OF GASTROPARESIS
Henry P. Parkman
Temple Univ School of Medicine, Philadelphia, PA

Sp950
MEDICAL MANAGEMENT OF GASTROPARESIS
Michael Camilleri
Mayo Clinic College of Medicine, Rochester, MN

Sp951
ENDOSCOPIC TREATMENT OF GASTROPARESIS
Kevin El-Hayek
MetroHealth Medical Center, Cleveland, OH

Sp952
SURGICAL TREATMENT OF GASTROPARESIS
Brian R. Davis
Texas Tech Health Sciences Center E, El Paso, TX

<< Sunday | Program | Tuesday >>